News, Resources, Updates
A scientific hub to keep you informed about our latest research and company updates.
How do you build the right immunotoxicity assessment strategy for your nonclinical safety GLP program?
From standard toxicity studies and follow-up immune-function testing to immunogenicity assessment, test-system selection, and GLP execution, this article explores how to build an effective immunotoxicity assessment strategy for biotechnology-derived therapeutics.The...
Neurodevelopmental disorder mouse models at InnoSer — TSC, Rett & STXBP1
in this month's update, we invite you to explore recent developments in rare neurodevelopmental disorders associated with epilepsy and seizure phenotypes. We highlight emerging therapeutic approaches, discuss the importance of selecting translationally relevant...
Your compound has shown efficacy in a preclinical disease model – now what? Moving from exploratory studies to GLP toxicology studies
A practical guide to transitioning from exploratory studies to GLP toxicology when outsourcing your non-clinical safety program to a specialist GLP toxicology CRO.Demonstrating efficacy in a disease model represents a major milestone in preclinical drug development....
Plasma NfL, p-tau217, or Aβ42/40: Which Alzheimer’s disease biomarkers should you include in your preclinical efficacy study?
A practical guide to preclinical Alzheimer’s disease biomarkers panel selection when you’re considering outsourcing to a specialist neurology CRO Biomarkers have transformed Alzheimer's disease clinical trials, enabling diagnosis confirmation for trial eligibility,...
Transgenic Amyloid, Tau, Seeding, or combined Amyloid/Tau pathology mouse models — which is the right one for your drug development program?
A practical guide to model selection when outsourcing your Alzheimer's disease efficacy study to a specialist neurology CRO Choosing the right Alzheimer's disease mouse model is one of the most consequential early decisions in a preclinical drug development program....
Morris Water Maze, Rotarod and beyond: How do you build a comprehensive behavioral test battery when outsourcing your preclinical Alzheimer’s disease efficacy study?
A practical introduction to behavioural test battery selection when outsourcing your Alzheimer's disease efficacy study to a specialist neurology CRO When outsourcing a preclinical Alzheimer's disease efficacy study, behavioral endpoint selection is one of the most...
info@innoserlaboratories.com





